Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2026 Filed Jul 28, 2026 21:01 UTC |
FRENKEL JACOB ADirector
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-087588 · tm2621485-2_4seq1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,777 F1 · shares: Represents shares of restricted stock units ("RSUs") issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the "Consulting Agreement") and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date. Read SEC document |
| July 24, 2026 Filed Jul 28, 2026 21:00 UTC |
Pitts Peter JoeDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 900,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001104659-26-087584 · tm2621485-1_4seq1.xml · derivative · entry 1 Pitts Peter Joe · CIK 0002138486 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2036-07-24 F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F2 · derivative.exercise_date: The stock options vest over 48 months, with 25% vesting on July 24, 2027 and 1/48th vesting monthly thereafter, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 20, 2026 22:07 UTC |
Bairu MenghisteabDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.70 Strike: $0.70 | $105,000.00 |
DisclosureSEC source: 0001104659-26-064658 · tm267728-6_4seq1.xml · derivative · entry 1 Bairu Menghisteab · CIK 0001891933 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2036-02-26 F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 20, 2026 22:06 UTC |
Polverino Anthony J.Director
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.70 Strike: $0.70 | $105,000.00 |
DisclosureSEC source: 0001104659-26-064657 · tm267728-5_4seq1.xml · derivative · entry 1 Polverino Anthony J. · CIK 0001729957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2036-02-26 F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 20, 2026 22:05 UTC |
HARTOUNIAN HARTOUNDirector
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.70 Strike: $0.70 | $157,500.00 |
DisclosureSEC source: 0001104659-26-064656 · tm267728-4_4seq1.xml · derivative · entry 1 HARTOUNIAN HARTOUN · CIK 0001214476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2036-02-26 F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 20, 2026 22:03 UTC |
Lindborg StacyDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.70 Strike: $0.70 | $105,000.00 |
DisclosureSEC source: 0001104659-26-064653 · tm267728-3_4seq1.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2036-02-26 F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 20, 2026 22:02 UTC |
Naor NirDirector
|
GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.70 Strike: $0.70 | $126,000.00 |
DisclosureSEC source: 0001104659-26-064652 · tm267728-2_4seq1.xml · derivative · entry 1 Naor Nir · CIK 0001982278 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2036-02-26 F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 20, 2026 22:00 UTC |
Dagher Ibrahim B.Director
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.70 Strike: $0.70 | $157,500.00 |
DisclosureSEC source: 0001104659-26-064650 · tm267728-1_4seq1.xml · derivative · entry 1 Dagher Ibrahim B. · CIK 0002019599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2036-02-26 F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 29, 2026 21:02 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 1,800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-068339 · tm2615354-5_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,960 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 29, 2026 21:02 UTC |
Yablonka UriDirector · EVP & Chief Business Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-068338 · tm2615354-4_4seq1.xml · nonDerivative · entry 1 Yablonka Uri · CIK 0001608814 · Director · EVP & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,464 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 29, 2026 21:01 UTC |
FRENKEL JACOB ADirector
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-068336 · tm2615354-2_4seq1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,777 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 29, 2026 21:01 UTC |
Patlis AllaSee Remarks
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-068337 · tm2615354-3_4seq1.xml · nonDerivative · entry 1 Patlis Alla · CIK 0001639227 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,349 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 29, 2026 21:00 UTC |
ARBEL IRITDirector
|
GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-068335 · tm2615354-1_4seq1.xml · nonDerivative · entry 1 ARBEL IRIT · CIK 0001245607 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,054 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:36 UTC |
FRENKEL JACOB ADirector
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000894 · tm251864-9_4seq1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,777 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:36 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000895 · tm251864-10_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,960 F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:34 UTC |
Polverino Anthony J.Director
|
GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000893 · tm251864-8_4seq1.xml · nonDerivative · entry 1 Polverino Anthony J. · CIK 0001729957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,730 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:34 UTC |
Yablonka UriDirector · EVP & Chief Business Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000892 · tm251864-7_4seq1.xml · nonDerivative · entry 2 Yablonka Uri · CIK 0001608814 · Director · EVP & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,464 F3 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:34 UTC |
Yablonka UriDirector · EVP & Chief Business Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000892 · tm251864-7_4seq1.xml · nonDerivative · entry 1 Yablonka Uri · CIK 0001608814 · Director · EVP & Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,464 F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan (the "Plan"). The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:33 UTC |
Patlis AllaSee Remarks
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000891 · tm251864-6_4seq1.xml · nonDerivative · entry 1 Patlis Alla · CIK 0001639227 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,349 F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:32 UTC |
Naor NirDirector
|
GrantCommon Stock | 30,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000890 · tm251864-5_4seq1.xml · nonDerivative · entry 1 Naor Nir · CIK 0001982278 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,465 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:32 UTC |
Lindborg StacyDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000889 · tm251864-4_4seq1.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,229 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:31 UTC |
HARTOUNIAN HARTOUNEVP, Chief Operating Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000888 · tm251864-3_4seq1.xml · nonDerivative · entry 1 HARTOUNIAN HARTOUN · CIK 0001214476 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,000 F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:31 UTC |
Bairu MenghisteabDirector
|
GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000887 · tm251864-2_4seq1.xml · nonDerivative · entry 1 Bairu Menghisteab · CIK 0001891933 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:30 UTC |
ARBEL IRITDirector
|
GrantCommon Stock | 30,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000885 · tm251864-1_4seq1.xml · nonDerivative · entry 1 ARBEL IRIT · CIK 0001245607 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,054 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| January 01, 2025 Filed Jan 7, 2025 21:11 UTC |
Dagher Ibrahim B.Chief Medical Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001674 · tm251864-11_4seq1.xml · nonDerivative · entry 1 Dagher Ibrahim B. · CIK 0002019599 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,849 F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 12:00 UTC |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 1,836 | $3.43 | $6,292.34 |
DisclosureSEC source: 0001104659-24-105215 · tm2425378-1_4seq1.xml · nonDerivative · entry 2 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,960 F2 · shares: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. F2 · price: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.40 to $3.45, inclusive. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 12:00 UTC |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 22,000 | $0.23 | $5,016.00 |
DisclosureSEC source: 0001104659-24-105215 · tm2425378-1_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,186,865 F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.2258 to $0.2302, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4. Read SEC document |
| July 19, 2024 Filed Jul 24, 2024 20:05 UTC |
Dagher Ibrahim B.Chief Medical Officer
|
SaleCommon Stock | 63,000 | $0.35 | $22,068.90 |
DisclosureSEC source: 0001104659-24-082328 · tm2420104-1_4seq1.xml · nonDerivative · entry 1 Dagher Ibrahim B. · CIK 0002019599 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.3455 to $0.366, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 01:04 UTC |
HARTOUNIAN HARTOUNEVP, Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001104659-24-074873 · tm2418256-2_4seq1.xml · derivative · entry 2 HARTOUNIAN HARTOUN · CIK 0001214476 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-06-24 F2 · derivative.exercise_date: The option (the "Option"), awarded under the Plan, shall vest and become exercisable as to 25% of the underlying shares on June 24, 2025, and the remaining shares underlying the Option shall vest and become exercisable in equal quarterly installments thereafter, until fully vested and exercisable on the fourth anniversary of the grant date, provided that the Reporting Person remains employed by Issuer from the date of grant through each applicable vesting date. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 01:04 UTC |
HARTOUNIAN HARTOUNEVP, Chief Operating Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-074873 · tm2418256-2_4seq1.xml · nonDerivative · entry 1 HARTOUNIAN HARTOUN · CIK 0001214476 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Issuer's 2014 Stock Incentive Plan (the "Plan"). The RSUs will vest in full on June 24, 2025, provided that the Reporting Person remains employed by Issuer from the date of grant through the vesting date. Read SEC document |
| May 28, 2024 Filed Jun 3, 2024 13:00 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 15,000 | $0.52 | $7,774.50 |
DisclosureSEC source: 0001104659-24-067529 · tm2416255-1_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,164,865 F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 28, 2024 Filed Jul 31, 2024 20:09 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 15,000 | $0.52 | $7,774.50 |
DisclosureSEC source: 0001104659-24-084344 · tm2420560-7_4aseq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,164,865 F1 · kind: On June 3, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 22, 2024 Filed May 23, 2024 10:00 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 25,000 | $0.64 | $16,000.00 |
DisclosureSEC source: 0001104659-24-064415 · tm2415334-1_4seq1.xml · nonDerivative · entry 2 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,149,865 Read SEC document |
| May 22, 2024 Filed Jul 31, 2024 20:08 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 25,000 | $0.64 | $16,000.00 |
DisclosureSEC source: 0001104659-24-084343 · tm2420560-6_4aseq1.xml · nonDerivative · entry 2 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,149,865 F1 · kind: On May 23, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. Read SEC document |
| May 21, 2024 Filed May 23, 2024 10:00 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 25,000 | $0.58 | $14,475.00 |
DisclosureSEC source: 0001104659-24-064415 · tm2415334-1_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,124,865 Read SEC document |
| May 21, 2024 Filed Jul 31, 2024 20:08 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 25,000 | $0.58 | $14,475.00 |
DisclosureSEC source: 0001104659-24-084343 · tm2420560-6_4aseq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,124,865 F1 · kind: On May 23, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. Read SEC document |
| May 13, 2024 Filed May 14, 2024 11:53 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 10,000 | $0.49 | $4,900.00 |
DisclosureSEC source: 0001104659-24-060889 · tm2414376-1_4seq1.xml · nonDerivative · entry 3 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,099,865 Read SEC document |
| May 13, 2024 Filed Jul 31, 2024 20:07 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 10,000 | $0.49 | $4,900.00 |
DisclosureSEC source: 0001104659-24-084341 · tm2420560-5_4aseq1.xml · nonDerivative · entry 3 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,099,865 F1 · kind: On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. Read SEC document |
| May 11, 2024 Filed May 14, 2024 11:53 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 10,000 | $0.47 | $4,665.00 |
DisclosureSEC source: 0001104659-24-060889 · tm2414376-1_4seq1.xml · nonDerivative · entry 2 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,089,865 Read SEC document |
| May 11, 2024 Filed Jul 31, 2024 20:07 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 10,000 | $0.47 | $4,665.00 |
DisclosureSEC source: 0001104659-24-084341 · tm2420560-5_4aseq1.xml · nonDerivative · entry 2 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,089,865 F1 · kind: On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. Read SEC document |
| May 10, 2024 Filed May 14, 2024 11:53 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 20,000 | $0.47 | $9,300.00 |
DisclosureSEC source: 0001104659-24-060889 · tm2414376-1_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,079,865 Read SEC document |
| May 10, 2024 Filed Jul 31, 2024 20:07 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 20,000 | $0.47 | $9,300.00 |
DisclosureSEC source: 0001104659-24-084341 · tm2420560-5_4aseq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,079,865 F1 · kind: On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. Read SEC document |
| May 07, 2024 Filed May 7, 2024 23:41 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 66,300 | $0.37 | $24,816.09 |
DisclosureSEC source: 0001104659-24-058218 · tm2413818-1_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,059,865 F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3738 to $0.3747, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 07, 2024 Filed Jul 31, 2024 20:07 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 66,300 | $0.37 | $24,816.09 |
DisclosureSEC source: 0001104659-24-084339 · tm2420560-4_4aseq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,059,865 F1 · kind: On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3738 to $0.3747, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 06, 2024 Filed May 7, 2024 13:14 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 135,000 | $0.38 | $50,665.50 |
DisclosureSEC source: 0001104659-24-057784 · tm2413699-1_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 993,565 F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 06, 2024 Filed Jul 31, 2024 20:06 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 135,000 | $0.38 | $50,665.50 |
DisclosureSEC source: 0001104659-24-084337 · tm2420560-3_4aseq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 993,565 F1 · kind: On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 19, 2024 Filed Apr 25, 2024 20:01 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 15,000 | $0.52 | $7,798.50 |
DisclosureSEC source: 0001104659-24-051948 · tm2412707d1_4seq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 858,565 Read SEC document |
| April 19, 2024 Filed Jul 31, 2024 20:06 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 15,000 | $0.52 | $7,798.50 |
DisclosureSEC source: 0001104659-24-084336 · tm2420560-2_4aseq1.xml · nonDerivative · entry 1 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 858,565 F1 · kind: On April 25, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 10:05 UTC |
Lebovits ChaimPresident & CEO
|
GrantCommon Stock | 115,072 | $0.53 | $60,470.34 |
DisclosureSEC source: 0001104659-24-049027 · tm2412256-1_4seq1.xml · nonDerivative · entry 2 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843,565 F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.4936 to $0.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 18, 2024 Filed Jul 31, 2024 20:05 UTC Amendment |
Lebovits ChaimPresident & CEO
|
PurchaseCommon Stock | 115,072 | $0.53 | $60,470.34 |
DisclosureSEC source: 0001104659-24-084334 · tm2420560-1_4aseq1.xml · nonDerivative · entry 2 Lebovits Chaim · CIK 0001406302 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843,565 F1 · kind: On April 19, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'. F3 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.4936 to $0.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.